Trametinib is an anti-cancer medication used to treat various types of cancers, particularly those with BRAF mutations, such as melanoma and non-small cell lung cancer. It belongs to the class of MAPK pathway inhibitors and works by blocking the activity of specific proteins involved in cancer cell growth and survival. Trametinib is often used in combination with other targeted therapies. Common side effects may include rash, diarrhea, and fatigue. In summary, Trametinib is a vital treatment option for targeted cancer therapy.
Trametinib inhibits the MEK1 and MEK2 proteins in the MAPK signaling pathway, leading to reduced proliferation and survival of cancer cells with BRAF mutations.
No published brands for this salt yet.